Skip to main content
. 2014 May 8;5:203. doi: 10.3389/fimmu.2014.00203

Figure 2.

Figure 2

Putative metabolic pathways and upstream regulators in tolerogenic versus immunogenic dendritic cells. In red examples are depicted of pharmacological approaches currently tested or used in other therapeutic settings, that could be used to manipulate DC metabolism.